ARE THEY ALSO MIND COLONIZERS? EXPLORING THE ASSOCIATION BETWEEN GUT MICROBIOTA AND DEPRESSION
Abstract
The association of the gut microbiota with many diseased and healthy state is currently of global interest. Depression is a disorder that is etiologically heterogeneous. There is a correlation between gut microbiota, immune responses, behaviour and pathophysiology of depression. These shows the link of microbiome and mental health, which point to a possible future of manipulation of gut microbiota for better health. This mini review compiled some existing literature on the relationship between depression and human gut microbiota.
References
Adeoshun F.G, Ayeni F.A. (2016). Antagonistic effect of four Lactobacillus sp. on multidrug resistant Klebsiella sp. GF01 in coculture. African Journal of Pharmaceutical Research and Development. 8 (2): 81-87.
Adeoshun F.G, Ruppitsch W, Allerberger F, Ayeni F.A. (2019). Prevalence and Antimicrobial Properties of Lactic Acid Bacteria in Nigerian Women during the Menstrual Cycle. Pol J Microbiol. 2019; 68(2):203-209.
Adetoye A, Pinloche E, Adeniyi BA, Ayeni FA. (2018). Characterization and anti-salmonella activities of lactic acid bacteria isolated from cattle faeces. BMC Microbiol. 2018. 18(1):96.
Afolayan A.O., Ayeni F.A.. (2017). Antagonistic effects of three lactic acid bacterial strains isolated from Nigerian indigenous fermented Ogi on E. coli EKT004 in co-culture. Acta Alimentaria. 46 (1): 1–8.
Afolayan A.O, Ayeni F.A, Moissl-Eichinger C, Gorkiewicz G, Halwachs B, Högenauer C. (2019). Impact of a Nomadic Pastoral Lifestyle on the Gut Microbiome in the Fulani Living in Nigeria. Front Microbiol. ;10:2138.
Ait-Belgnaoui A., Durand H., Cartier C., Chaumaz G., Eutamene H., Ferrier L., Houdeau E., Fioramonti J., Bueno L., Theodorou V. (2012). Prevention of gut leakiness by a probiotic treatment leads to attenuated HPA response to an acute psychological stress in rats. Psychoneuroendocrinology, 37(11): 1885-1895.
Aizawa E., Tsuji H., Asahara T., Takahashi T., Teraishi T., Yoshida S., Ota M., Koga N., Hattori K., Kunugi H. (2016). Possible association of Bifidobacterium and Lactobacillus in the gut microbiota of patients with major depressive disorder. J. Affect. Disord. 202, 254–257
American Psychiatric Association (APA). (2013). Diagnostic and Statistical Manual of Mental Disorders (2013): DSM-5,5th ed; Washington, D.C, .
Ayeni A.O, Ayeni F.A. (2016). Antagonistic effects of lactic and acetic acid bacteria on Shigella sp. SS10 in co-culture. TAF Preventive Medicine Bulletin. 15 (1): 27-31.
Ayeni F.A., Sánchez B. Adeniyi B.A., de los Reyes-Gavilán C.G, Margolles A. Ruas-Madiedo P. (2011): Evaluation of the functional potential of Weissella and Lactobacillus isolates obtained from Nigerian traditional fermented foods and cow´s intestine. International Journal of Food Microbiology 147. (2): 97-104.
Ayeni F.A, Biagi E, Rampelli S, Fiori J, Soverini M, Audu H.J, Cristino S, Caporali L, Schnorr S.L, Carelli V, Brigidi P, Candela M, and Turroni S. (2018). Infant and adult gut microbiome and metabolome in rural Bassa and urban settlers from Nigeria. Cell Reports. 23, 3056-3067.
Ayeni A.O., Ruppitsch W, Ayeni F.A.. (2019). Characterization of bacteria in Nigerian Yogurt as promising alternative to antibiotics in gastrointestinal infections. Journal of Dietary Supplements. 16(2):141-151.
Bäckhed F. (2011). Programming of host metabolism by the gut microbiota. Annals of Nutrition and Metabolism, Suppl 58(2): 44-52.
Baes C. V., Martins C. M., Tofoli S. M., and Juruena M. F. (2014). Early life stress in depressive patients: HPA axis response to GR and MR agonist. Frontiers in Psychiatry. 5:2.
Barrett E., Kerr C., Murphy K., O'sullivan O., Ryan C. A., Dempsey E. M. (2013). The individual-specific and diverse nature of the preterm infant microbiota. Archives of Disease in Childhood: Fetal and Neonatal Edition. 98, F334–F340.
Barrett E., Ross R. P., O'Toole P. W., Fitzgerald G. F., & Stanton C. (2012). γAminobutyric acid production by culturable bacteria from the human intestine. Journal of applied microbiology, 113(2): 411-417.
Bendtsen K. M. B., Krych L., Sørensen D. B., Pang W., Nielsen D. S., Josefsen K., Hansen L. H., Sørensen S. J. and Hansen A. K. (2012). Gut microbiota composition is correlated to grid floor induced stress and behavior in the BALB/c mouse. PloS one, 7(10): p.e46231
Bercik P., and Collins S. M. (2014). The effects of inflammation, infection and antibiotics on the microbiota-gut-brain axis. Advances in Experimental Medicine and Biology. 817, 279–289.
Bercik P., Denou E., Collins J., Jackson W., Lu J., Jury J., Deng Y., Blennerhassett P., Macri J., McCoy K. D. and Verdu E. F. (2011). The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology, 141(2): pp.599-609.
Bereswill S., Pyndt Jørgensen B., Hansen J. T., Krych L., Larsen C., Klein A. B., Nielsen D. S., Josefsen K., Hansen A. K., Sørensen D. B. (2014). A possible link between food and mood: dietary impact on gut microbiota and behavior in Balb/C mice. PLoS ONE 9, E103398
Bharwani A., Mian M. F., Surette M. G., Bienenstock J., Forsythe P. (2017). Oral Treatment with Lactobacillus rhamnosus attenuates behavioural deficits and immune changes in chronic social stress. BMC Medicine.15, 7.
Bilbo S. D., and Schwarz J. M. (2012). The immune system and developmental programming of brain and behavior. Frontiers in Neuroendocrinology, 33(3): 267-286.
Bindels L. B., Delzenne N. M., Cani P. D., and Walter J. (2015). Towards a more comprehensive concept for prebiotics. Nature Reviews Gastroenterology and. Hepatology. 12, 303–310.
Bloomfield S.F, Rook G.A.W, Scott E.A., Shanahan F, Stanwell-Smith R, and Turner P. (2016). Time to abandon the hygiene hypothesis: new perspectives on allergic disease, the human microbiome, infectious disease prevention and the role of targeted hygiene. Perspectives in Public Health. 136(4): 213–224.
Borre Y. E., O'Keeffe G. W., Clarke G., Stanton C., Dinan T. G., and Cryan J. F. (2014). Microbiota and neurodevelopmental windows: implications for brain disorders. Trends in Molecular Medicine. 20, 509–518.
Byrne G, Rosenfeld G, Leung Y, Qian H, Raudzus J, Nunez C and Bressler B. (2017). Prevalence of anxiety and depression in patients with inflammatory bowel disease. Canadian Journal of Gastroenterology and Hepatology, : 6496727.
Chen, L., Deng, H., Cui, H., Fang, J., Zuo, Z., Deng, J., Li, Y., Wang, X., & Zhao, L. (2017). Inflammatory responses and inflammation-associated diseases in organs. Oncotarget, 9(6), 7204–7218.
Clarke G., Grenham S., Scully P., Fitzgerald P., Moloney R. D., Shanahan F. (2013). The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Molecular Psychiatry 18, 666–673.
Dalile, B., Van Oudenhove, L., Vervliet, B. Verbeke K.. (2019). The role of short-chain fatty acids in microbiota–gut–brain communication. Nat Rev Gastroenterol Hepatol 16, 461–478
Dantzer R., O’Connor J. C., Freund G. G., Johnson R. W., Kelley K. W. (2008). From inflammation to sickness and depression: when the immune system subjugates the brain. Nature Reviews Neuroscience., 9(1): 46-56.
Dash S., Clarke G., Berk M., Jacka F. N. (2015). The gut microbiome and diet in psychiatry: focus on depression. Current Opinion in Psychiatry, 28(1): 1-6.
Davari S., Talaei S. A., Alaei H., Salami M. (2013). Probiotics treatment improves diabetes-induced impairment of synaptic activity and cognitive function: behavioral and electrophysiological proofs for microbiome-gut-brain axis. Neuroscience, 240, 287- 296.
De Palma G., Blennerhassett P., Lu J., Deng Y., Park A. J., Green W. (2015). Microbiota and host determinants of behavioural phenotype in maternally separated mice. Nature Communications. 6:7735.
De Palma G., Lynch M. D., Lu J., Dang V. T., Deng Y., Jury J., Umeh G., Miranda P. M., Pastor M. P., Sidani S. and Pinto-Sanchez M. I. (2017). Transplantation of fecal microbiota from 65 patients with irritable bowel syndrome alters gut function and behavior in recipient mice. Science translational medicine, 9(379): 6397.
Desbonnet L., Garrett L., Clarke G., Bienenstock J., Dinan T. G. (2008). The probiotic Bifidobacteria infantis: An assessment of potential antidepressant properties in the rat. Journal of Psychiatry Research., 43(2): 164-174.
D'haens G., Ferrante M., Vermeire S., Baert F., Noman M., Moortgat L., Geens P., Iwens D., Aerden I., Van Assche G. and Van Olmen G., (2012). Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease. Inflammatory bowel diseases, 18(12): pp.2218-2224.
Didari T., Mozaffari S., Nikfar S. and Abdollahi M. (2015). Effectiveness of probiotics in irritable bowel syndrome: updated systematic review with meta-analysis. World Journal of Gastroenterology. 21, 3072–3084.
Diop L., Guillou S., Durand H. (2008). Probiotic food supplement reduces stress-induced gastrointestinal symptoms in volunteers: a double-blind, placebo-controlled, randomized trial. Nutrition Research. 28(1): 1-5.
Distrutti E, Monaldi L, Ricci P, Fiorucci S. (2016). Gut microbiota role in irritable bowel syndrome: New therapeutic strategies. World J Gastroenterol. 22(7):2219-2241.
Dinan T. G. and Cryan J. F. (2013). Melancholic microbes: a link between gut microbiota and depression? Neurogastroenterology and Motility. 25, 713–719.
Dominguez-Bello M. G., Costello E. K., Contreras M., Magris M., Hidalgo G., Fierer N. (2010). Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. PNAS,U.S.A. 107, 11971–11975.
Farzi A, Fröhlich E.E, Holzer P. (2018). Gut Microbiota and the Neuroendocrine System. Neurotherapeutics. ;15(1):5-22.
Fidder H., Schnitzler F., Ferrante M., Noman M., Katsanos K., Segaert S., Henckaerts L., Van Assche G., Vermeire S. and Rutgeerts P. (2009). Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study. Gut, 58(4): pp.501-508.
Flowers S.A, Ellingrod V.L.(2015). The Microbiome in Mental Health: Potential Contribution of Gut Microbiota in Disease and Pharmacotherapy Management. Pharmacotherapy. 35(10):910-916
Galland L. (2014). The gut microbiome and the brain. J Med Food.;17(12):1261-72.
Graff L. A., Walker J. R. and Bernstein C. N. (2009). Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management. Inflammatory bowel diseases, 15(7): 1105-1118.
Guida F., Turco F., Iannotta M., De Gregorio D., Palumbo I., Sarnelli G. (2018). Antibiotic-induced microbiota perturbation causes gut endocannabinoidome changes, hippocampal neuroglial reorganization and depression in mice. Brain Behaviour and Immun. 67, 230–45.
Himmerich H, Patsalos O, Lichtblau N, Ibrahim MAA, Dalton B. (2019). Cytokine Research in Depression: Principles, Challenges, and Open Questions. Front Psychiatry. ;10:30.
Horst S., Chao A., Rosen M., Nohl A., Duley C., Wagnon J. H., Beaulieu D. B., Taylor W., Gaines L. and Schwartz D. A. (2015). Treatment with immunosuppressive therapy may improve depressive symptoms in patients with inflammatory bowel disease. Digestive diseases and sciences, 60(2): p.465.
Hsiao E. Y., Sara McBride W., Hsien S., Sharon G., Embriette Hyde R., McCue T. (2013). Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell. 155, 1451–63.
Jakobsson H. E., RodrÃguez-Piñeiro A. M., Schütte A., Ermund A., Boysen P., Bemark M. (2015). The composition of the gut microbiota shapes the colon mucus barrier. EMBO Reports. 16, 164–177.
Jeffery I. B., O'Toole P. W., Öhman L., Claesson M. J., Deane J., Quigley E. M. (2012). An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut. 61, 997–1006.
Jiang H., Ling Z., Zhang Y., Mao H., Ma Z., Yin Y., Wang W., Tang W., Tan Z., Shi J. (2015). Altered fecal microbiota composition in patients with major depressive disorder. Brain Behaviour and Immunology. 48, 186–194.
Karson A., Demirtaş T., Bayramgürler D., Balcı F. and Utkan T. (2013). Chronic Administration of Infliximab (TNF-α Inhibitor) decreases depression and anxiety-like behaviour in rat model of chronic mild stress. Basic & clinical pharmacology & toxicology, 112(5): 335- 340.
Kelly J. R., Kennedy P. J., Cryan J. F., Dinan T. G., Clarke G. and Hyland N. P. (2015). Breaking down the barriers: the gut microbiome, intestinal permeability and stress related psychiatric disorder. Frontiers in Cellular Neuroscience. 9, 392
Kelly J. R., Borre Y., O'Brien C., Patterson E., El Aidy S., Deane J., Kennedy P. J., Beers S., Scott K., Moloney G. and Hoban A. E. (2016). Transferring the blues: depression-associated gut microbiota induces neuro behavioural changes in the rat. Journal of Psychiatric Research, 82, pp.109-118.
Kennedy P. J., Clarke G., O'Neill A., Groeger J. A., Quigley E. M., Shanahan F. (2014). Cognitive performance in irritable bowel syndrome: evidence of a stress-related impairment in visuospatial memory. Psychology and Medicine. 44, 1553–1566.
Kéri S., Szabó C. and Kelemen O. (2014). Expression of toll-like receptors in peripheral blood mononuclear cells and response to cognitive-behavioral therapy in major depressive disorder. Brain Behaviour and Immunology. 40, 235–243.
Leclercq S., De Saeger C., Delzenne N., de Timary P. and Stärkel P. (2014). Role of inflammatory pathways, blood mononuclear cells, and gut-derived bacterial products in alcohol dependence. Biology and Psychiatry 76, 725–733.
Lennon E. M., Maharshak N., Elloumi H., Borst L., Plevy S. E. and Moeser A. J. (2013). Early life stress triggers persistent colonic barrier dysfunction and exacerbates colitis in adult IL-10-/- mice. Inflammatory Bowel Diseases. 19, 712–719.
Liang S., Wang T., Hu X., Luo J., Li W., Wu X., Duan Y., Jin F. (2015). Administration of Lactobacillus helveticus Ns8 improves behavioral, cognitive, and biochemical aberrations caused by chronic restraint stress. Neuroscience 310, 561–577.
Liu Y., Zhang L., Wang X., Wang Z., Zhang J., Jiang R., Wang X., Wang K., Liu Z., Xia Z. (2016). Similar fecal microbiota signatures in patients with diarrhea-predominant irritable bowel syndrome and patients with depression. Clinical Gastroenterology and Hepatology. 14, 1602–1611.
Lucas M., Chocano-Bedoya P., Shulze M. B., Mirzaei F., O'Reilly E. J., Okereke O. I. (2014). Inflammatory dietary pattern and risk of depression among women. Brain Behavior and Immunology. 36, 46–53.
Lyte M., Li W., Opitz N., Gaykema R. P. and Goehler L. E. (2006). Induction of anxiety-like behavior in mice during the initial stages of infection with the agent of murine colonic hyperplasia Citrobacter rodentium. Physiology Behaviours. 89, 350–357.
Maes M., Kubera M., Leunis J. C. and Berk M. (2012). Increased IgA and IgM responses against gut commensals in chronic depression: further evidence for increased bacterial translocation or leaky gut. Journal of Affective Disorders. 141, 55–62.
Maes M., Kubera M., Leunis J. C., Berk M., Geffard M., Bosmans E. (2013). In depression, bacterial translocation may drive inflammatory responses, oxidative and nitrosative stress, (O&NS), and autoimmune responses directed against O&NS-damaged neoepitopes. Acta Psychiatric Scandals. 127, 344–54.
Marin I. A., Goertz J. E., Ren T., Rich S. S., Onengut-Gumuscu S., Farber E., Wu M., Overall C. C., Kipnis J., Gaultier A. (2017). Microbiota alteration is associated with the development of stress-induced despair behavior. Science Reports. 7, 43859
Marques T. M., Wall R., Ross R. P., Fitzgerald G. F., Ryan C. A. and Stanton, C. (2010). Programming infant gut microbiota: influence of dietary and environmental factors. Current Opinion in Biotechnology. 21, 149–156.
Mayer E. A. (2011). Gut feelings: the emerging biology of gut–brain communication. Nature Reviews Neuroscience, 12(8): 453-466.
Mayer E. A., Knight R., Mazmanian S. K. and Cryan J. F. (2014). Gut microbes and the brain: paradigm shift in neuroscience. Journal of Neuroscience. 34, 15490–15496.
Miller A.H. and Raison C.L. (2016). The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nature Reviews Immunology. 16(1): 22–34
Mudyanadzo TA, Hauzaree C, Yerokhina O, Architha NN, Ashqar HM. (2018). Irritable Bowel Syndrome and Depression: A Shared Pathogenesis. Cureus. 0(8):e3178.
Naseribafrouei A., Hestad K., Avershina E., Sekelja M., Linløkken A., Wilson R. (2014). Correlation between the human fecal microbiota and depression. Neurogastroenterology and Motility. 26, 1155–1162.
Noble E. E., Hsu T. M., Kanoski S. E. (2017). Gut to brain dysbiosis: mechanisms linking western diet consumption, the microbiome, and cognitive impairment. Frontiers in Behavioural Neuroscience. 11, 9.
O'Mahony S. M., Marchesi J. R., Scully P., Codling C., Ceolho A. M., Quigley E. M., Cryan J. F. and Dinan T. G. (2009). Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses. Biological psychiatry, 65(3): pp.263-267.
O'Mahony S. M., Hyland N. P., Dinan T. G., Cryan J. F. (2011). Maternal separation as a model of brain-gut axis dysfunction. Psychopharmacology, 214, 71-88.
Orel R. and Kamhi Trop T. (2014). Intestinal microbiota, probiotics and prebiotics in inflammatory bowel disease. World Journal of Gastroenterology. 20, 11505–11524.
Park A. J., Collins J., Blennerhassett P. A., Ghia J. E., Verdu E. F., Bercik P., Collins S. M. (2013). Altered colonic function and microbiota profile in a mouse model of chronic depression. Neurogastroenterology and Motility., 25(9): 733-e575.
Pinto-Sanchez M. I., Ford A. C., Avila C. A., Verdu E. F., Collins S. M., Morgan D. (2015). Anxiety and depression increase in a stepwise manner in parallel with multiple FGIDs and symptom severity and frequency. American Journal of Gastroenterology. 110, 1038–1048.
Pozuelo M., Panda S., Santiago A., Mendez S., Accarino A., Santos J. (2015). Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome. Science Reports. 5:12693.
Pyndt Jorgensen B., Hansen J. T., Krych L., Larsen C., Klein A. B., Nielsen D. S., Josefsen K., Hansen A. K., Sorensen D. B. (2014). A possible link between food and mood: dietary impact on gut microbiota and behavior in BALB/c mice. PLoS One, 9.8. e103398.
Raison C. L., Rutherford R. E., Woolwine B. J., Shuo C., Schettler P., Drake D. F. and Miller A. H. (2013). A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA psychiatry, 70(1): 31-41.
Rajilic-Stojanovic M., Biagi E., Heilig H. G., Kajander K., Kekkonen R. A., Tims S. (2011). Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology. 141, 1792–1801.
Russell W. R., Hoyles L., Flint H. J. and Dumas M. E. (2013). Colonic bacterial metabolites and human health. Current Opinion in Microbiology. 16, 246–254.
Remus J. L. and Dantzer R. (2016). Inflammation models of depression in rodents: relevance to psychotropic drug discovery. International Journal of Neuropsychopharmacology. 19(9): pyw028.
Slykerman R. F., Thompson J., Waldie K. E., Murphy R., Wall C., Mitchell E. A. (2017). Antibiotics in the first year of life and subsequent neurocognitive outcomes. Acta Paediatrics. 106, 87–94.
Skonieczna-Å»ydecka, K., Grochans, E., Maciejewska, D., Szkup, M., Schneider-Matyka, D., Jurczak, A., Åoniewski, I., Kaczmarczyk, M., Marlicz, W., CzerwiÅ„ska-Rogowska, M., PeÅ‚ka-Wysiecka, J., Dec, K., and Stachowska, E. (2018). Faecal Short Chain Fatty Acids Profile is Changed in Polish Depressive Women. Nutrients, 10(12), 1939.
Sood R., Gracie D. J., Law G. R. and Ford A. C. (2015). Systematic review with meta-analysis: the accuracy of diagnosing irritable bowel syndrome with symptoms, biomarkers and/or psychological markers. Alimentary Pharmacology and Therapeutics. 42, 491–503.
Strachan D. P. (1989). Hay fever, hygiene, and household size. BMJ 299, 1259–1260.
Sylviaa K.E. and Demasa. G.E. (2018). A gut feeling: Microbiome-brain-immune interactions modulate social and affective behaviours. Hormones and Behavior. 99, 41–49
Syed S.A. and Nemeroff C.B. (2017). Early life stress, mood, and anxiety disorders. Chronic Stress (Thousand Oaks). 1: 10.1177/2470547017694461.
Tillisch K., Labus J., Kilpatrick L., Jiang Z., Stains J., Ebrat B. (2013). Consumption of fermented milk product with probiotic modulates brain activity. Gastroenterology 144, 1394–1401, 1401e1-4.
Thursby E and Juge N. (2017). Introduction to the human gut microbiota . Biochemical Journal 474: 1823–1836
Tlaskalová-Hogenova H., StÄ›panková R., Kozáková H., Hudcovic T., Vannucci L., TuÄková L. (2011). The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases. Cellular Molecular Immunology. 8, 110–120.
Vicario M., González-Castro A. M., Martinez C., Lobo B., Pigrau M., Guilarte M. (2015). Increased humoral immunity in the jejunum of diarrhoea-predominant irritable bowel syndrome associated with clinical manifestations. Gut. 64, 1379–1388.
Villani A. C., Lemire M., Thabane M., Belisle A., Geneau G., Garg A. X. (2010). Genetic risk factors for post-infectious irritable bowel syndrome following a waterborne outbreak of gastroenteritis. Gastroenterology 138, 1502–1513.
Vlainić, J. V., Šuran, J., Vlainić, T., & Vukorep, A. L. (2016). Probiotics as an Adjuvant Therapy in Major Depressive Disorder. Current neuropharmacology, 14(8), 952–958.
Williamson L. L., McKenney E. A., Holzknecht Z. E., Belliveau C., Rawls J. F., Poulton S. (2015). Got worms? Perinatal exposure to helminths prevents persistent immune sensitization and cognitive dysfunction induced by early-life infection. Brain Behaviour and Immunity. doi: 10.1016/j.bbi.2015.07.006.
Willing B. P., Russell S. L. and Finlay B. B. (2011). Shifting the balance: antibiotic effects on host-microbiota mutualism. Nature Review in Microbiology. 9, 233–243.
World Health Organization, (2001). Report of a joint FAO/WHO expert consultation on evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria Paper. 85.
World Health Organization. (2012). Depression, a global public health concern. Retrieved May 5, 2017, from http://www.who.int/mental_health/management/depression/who_paper_depression_wfmh_2012. pdf
Wu L. L., Chiu H. D., Peng W. H., Lin B. R., Lu K. S., Lu Y. Z. (2011). Epithelial inducible nitric oxide synthase causes bacterial translocation by impairment of enterocytic tight junctions via intracellular signals of Rho-associated kinase and protein kinase C zeta. Critical Care in Medicine. 39, 2087–2098.
Yamamura S., Morishima H., Kumano-go T., Suganuma N., Matsumoto H., Adachi H., Sigedo Y., Mikami A., Kai T., Masuyama A., Takano T., Sugita Y., Takeda M. (2009). The effect of Lactobacillus helveticus fermented milk on sleep and health perception in elderly subjects. European Journal of Clinical Nutrition., 63(1): 100-105.
Yatsunenko T., Rey F. E., Manary M. J., Trehan I., Dominguez-Bello M. G., Contreras M., Magris M., Hidalgo G., Baldassano R. N., Anokhin A. P. (2012). Human gut microbiome viewed across age and geography. Nature. 486, 222–227.
Yu M., Jia H., Zhou C., Yang Y., Zhao Y., Yang M., Zou Z. (2017). Variations in gut microbiota and fecal metabolic phenotype associated with depression by 16s rRNA gene sequencing and Lc/Ms-based metabolomics. Journal of Pharmaceutical amd Biomedical Analysis. 138, 231–239.
Zheng P., Zeng B., Zhou C., Liu M., Fang Z., Xu X. (2016). Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host's metabolism. Molecular Psychiatry. 21, 786–96.
FUDMA Journal of Sciences
